BioSpace News Archive

Regeneron Pharmaceuticals, Inc. announced a publication in the New England Journal of Medicine identifying for the first time a variant in the HSD17B13 gene that is associated with reduced risk of, or protection from, various chronic liver diseases for which there are currently no approved therapeutics.

Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals Inc. announced a collaboration to identify RNAi therapeutics for the chronic liver disease nonalcoholic steatohepatitis (NASH) and potentially other related diseases.

National Geographic and Sprint are proud to announce Asha Gummadi as the winner of the “CHASING GENIUS: Unlimited Innovation” challenge, which aimed at inspiring innovative ideas focused on wireless connectivity and the network of the future.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the pricing of an underwritten public offering of 8,500,000 shares of its common stock at a price to the public of $41.50 per share.

Avita Medical announced that Maricopa Integrated Health System (MIHS) Burn Center will hold a press conference today to highlight the recent treatment with RECELL® of a woman with necrotizing fasciitis, or flesh eating bacteria.

“We are excited to partner with WuXi AppTec Advanced Therapies to gain their expertise and cGMP manufacturing capabilities to support the ongoing development and anticipated global commercial demand for our lead cell therapy program, NLA101,” said Katie Fanning, President and Chief Executive Officer of Nohla.

Company is preparing for efficacy experiments in mice.

Silicon Valley-based Gore Innovation Center enters joint development agreement with graphene sensor startup Bonbouton

The candidate product is a combination of a medical device (implant) and a medicinal product (FGF1) for patients with complete spinal cord injury.

World’s most experienced research outsourcing marketplace strengthens data security systems in advance of upcoming GDPR implementation